CompletedPhase 2NCT03746080

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

Studying Gliosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Lawrence D Recht
Principal Investigator
Lawrence Recht
Stanford Cancer Institute Palo Alto
Intervention
Plerixafor(drug)
Enrollment
21 enrolled
Eligibility
18-75 years · All sexes
Timeline
2018 – 2024

Study locations (1)

Collaborators

Sanofi

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03746080 on ClinicalTrials.gov

Other trials for Gliosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Gliosarcoma →

← Back to all trials